STEVEN DEMETRIUS SARIS
Medical Practice in Ardmore, PA
License number
Pennsylvania MD021894E
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
Ardmore, PA 19003
Personal information
See more information about STEVEN DEMETRIUS SARIS at radaris.comName
Address
Phone
130 Valley Rd #12, Ardmore, PA 19003
130 Valley Rd, Ardmore, PA 19003
100 Church Rd, Ardmore, PA 19003
100 Church St, Media, PA 19003
130 Valley Rd, Ardmore, PA 19003
Professional information
See more information about STEVEN DEMETRIUS SARIS at trustoria.com
Dr. Steven D Saris, Ardmore PA - MD (Doctor of Medicine)
Dr. Steven D Saris, Ardmore PA - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
130 Valley Rd, Ardmore 19003
(610) 649-3150 (Phone)
(610) 649-3150 (Phone)
Certifications:
Internal Medicine, 1981
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
130 Valley Rd, Ardmore 19003
Bryn Mawr Hospital
130 South Bryn Mawr Ave, Bryn Mawr 19010
Bryn Mawr Hospital
130 South Bryn Mawr Ave, Bryn Mawr 19010
Education:
Medical School
Hahnemann University
Graduated: 1977
Med College Penn
Graduated: 1980
Hahnemann University
Graduated: 1977
Med College Penn
Graduated: 1980
Method Of Reducing Serum Uric Acid And/Or Increasing Renal Uric Acid Clearance With Thromboxane Synthetase Inhibitor Inhibitor And/Or Thromboxane Receptor Antagonist
Method Of Reducing Serum Uric Acid And/Or Increasing Renal Uric Acid Clearance With Thromboxane Synthetase Inhibitor Inhibitor And/Or Thromboxane Receptor Antagonist
US Patent:
5021448, Jun 4, 1991
Filed:
Feb 22, 1990
Appl. No.:
7/483160
Inventors:
Anthony J. Piraino - Media PA
Steven D. Saris - Ardmore PA
Steven D. Saris - Ardmore PA
Assignee:
Ciba-Geigy Corporation - Ardsley NY
International Classification:
A61K 31415, A61K 3140, A61K 3134, A61K 31335, A61K 31265, A61K 3118, A61K 31135, A61K 31095, A61K 3110, A61K 31075, A61K 31045, A61K 3105, A61K 3144
US Classification:
514415
Abstract:
A method of reducing serum uric acid and/or increasing renal clearance of uric acid in a mammal in need thereof comprising administering to such mammal a uricosuric effective amount of a thromboxane synthetase inhibitor, a thromboxane receptor antagonist, or both in a combined uricosuric effective amount is disclosed. Compositions having one or more of the foregoing in combination with one or more known uricosurics are also set forth.